• Our Members
  • Events
  • Contact us
AMR Industry Alliance
  • About us
    • Why the AMR Industry Alliance?
    • Board Members
  • Shared Goals
    • AMR Industry Declaration
    • Industry Roadmap for Progress on Combating Antimicrobial Resistance
    • Responsible Manufacturing
  • Why AMR?
  • Newsroom
  • Progress Report
  • In Action
Select Page
Peptilogics – Innovative Peptide-Based Platform to Develop a New Class of Potent Antibiotics

Peptilogics – Innovative Peptide-Based Platform to Develop a New Class of Potent Antibiotics

by mcwebmaster | Dec 15, 2017

iNtRON- N-Rephasin® SAL200 (Tonabacase)

iNtRON- N-Rephasin® SAL200 (Tonabacase)

by mcwebmaster | Dec 15, 2017

GSK – Sales Incentives Programme and Healthcare Provider Engagement Model

GSK – Sales Incentives Programme and Healthcare Provider Engagement Model

by mcwebmaster | Dec 15, 2017

GSK – Public-Private Partnerships to Share Knowledge and Expertise in R&D

GSK – Public-Private Partnerships to Share Knowledge and Expertise in R&D

by mcwebmaster | Dec 15, 2017

Cepheid – Global Laboratory Initiative

Cepheid – Global Laboratory Initiative

by mcwebmaster | Dec 15, 2017

« Older Entries
Next Entries »

stay informed

Subscribe to receive our updates

about us

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

read more
contact

AMR Industry Alliance Secretariat (IFPMA)
Chemin des Mines 9
P.O. Box 195
1211 Geneva 20
Switzerland
Email: info@amrindustryalliance.org

© AMR Industry Alliance 2017 - Contact us - Cookies Policy - Privacy Policy - Terms of use - Privacy Centre - Careers